Status:
COMPLETED
The Performance of Dexcom G6 Glucose Monitoring in Critically Ill Patients
Lead Sponsor:
Region Stockholm
Collaborating Sponsors:
DexCom, Inc.
Conditions:
Blood Glucose
Humans
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is an investigator-initiated, prospective, observational accuracy-study. The aim of the study is to test the feasibility, safety, and accuracy of a subcutaneous continuous glucose monitoring syst...
Detailed Description
The primary endpoint of the study is the mean absolute relative difference (MARD) in percent between CGM and arterial glucose values. Calculations show that 40 patients are required for a 95% confiden...
Eligibility Criteria
Inclusion
- Age ≥18 years
- Admitted to ICU at the Karolinska University Hospital Solna
- Indwelling arterial catheter in situ or expected to be inserted in the next 2 hours
- Six hours or less since intravenous insulin infusion was commenced or intravenous insulin infusion expected to commence within the next 2 hours
- Vasopressor infusion ongoing or expected to commence within the next 2 hours
- Mechanical ventilation ongoing or expected to commence within the next 2 hours
- Patient expected to stay in the ICU until the day after tomorrow
Exclusion
- Pregnancy
- Unable to get consent from patient or next-of-kin
- Patients in whom death is considered imminent (within 24 hours)
Key Trial Info
Start Date :
November 19 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 15 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05255783
Start Date
November 19 2021
End Date
May 15 2023
Last Update
November 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska University Hospital
Stockholm, Sweden, 17176